Community Scientific Subcommittee (CSS)
The Community Scientific Subcommittee (CSS) Representatives are a group of community volunteers that provides input and feedback to the AIDS Clinical Trials Group (ACTG). The CSS provides the community with an opportunity to voice concerns and discuss aspects of clinical trials, including protocol development, participant recruitment, and student implementation.
Kate is an HIV advocate with an interest in clinical advances related to HIV treatment, as well as public policies related to treatment and support. She is excited to be a Community Scientific Subcommittee representative for the REPRIEVE study, which seeks to answer a crucial question within the HIV community, concerning the increased risk of cardiovascular disease. Kate is also thrilled to be a part of the REPRIEVE study which actively seeks to include underserved populations, such as women, within clinical studies.
Kate currently serves on the Community Scientific Subcommittee of the AIDS Clinical Trials Group (ACTG). She is also a member of the Women’s Health Inter-Network Scientific Committee and Neurology Collaborative Science Group, within the ACTG. Kate also serves on the community advisory board with the Ohio State University AIDS Clinical Trials Unit.
In addition, Kate is actively involved with The Well Project, serving as a Community Advisory Board member, as well as a blogger for The Well Project’s, A Girl Like Me.
Kate graduated with a B.S. in Education from The Ohio State University and a post-baccalaureate Paralegal Certificate from Capital University Law School.
Karl has been involved with HIV/AIDS clinical trials and has been a community HIV/AIDS activist since 1993.
He was a member of the CCG (Community Constituency Group), now known as the GCAB for several years. When the Henry Ford Health Systems site was de-funded by the ACTG he remained involved with the ACTG and the GCAB and is a member of the CSS as a non-ACTG member. He continued to share the information with his local community and the prior CAB members of Henry Ford Health Systems. Karl was also one of the founding community members of the Ryan White Planning Council of Detroit. As part of his CSS activities Karl has served as a past CSS Co-Chair of the Under Represented Populations Sub-Committee, Adherence Intervention Working Group, Policy and Procedures Sub-Committee and the Community Partners Sub-Committee.
Karl participates in many HIV/AIDS activities in his community of Detroit, Michigan and is a clinical trial participant with the NIH for the past several years, including the Long Term Non-Progressors study.